<DOC>
	<DOC>NCT02906176</DOC>
	<brief_summary>A clinical trail to investigate the influence of SLCO2B1 polymorphism on the pharmacokinetic characteristics of voriconazole in CYP2C19 poor metabolizers</brief_summary>
	<brief_title>Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM</brief_title>
	<detailed_description />
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Healthy male volunteer who is a CYP2C19 Poor metabolizer with rs3781727 SNP wild or variant genotype History of clinically significant respiratory, cardiovascular, renal, hepatic, hematologic, neurological disorder</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>